Goulmy E - Search Results

1

Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients.

Oostvogels R, Kneppers E, Minnema MC, Doorn RC, Franssen LE, Aarts T, Emmelot ME, Spierings E, Slaper-Cortenbach I, Westinga K, Goulmy E, Lokhorst HM, Mutis T. Oostvogels R, et al. Among authors: goulmy e. Bone Marrow Transplant. 2017 Feb;52(2):228-237. doi: 10.1038/bmt.2016.250. Epub 2016 Nov 14. Bone Marrow Transplant. 2017. PMID: 27841858 Clinical Trial.

2

Expanding the immunotherapeutic potential of minor histocompatibility antigens.

Spierings E, Goulmy E. Spierings E, et al. Among authors: goulmy e. J Clin Invest. 2005 Dec;115(12):3397-400. doi: 10.1172/JCI27094. J Clin Invest. 2005. PMID: 16322786 Free PMC article.

3

Minor histocompatibility antigen typing by DNA sequencing for clinical practice in hematopoietic stem-cell transplantation.

Spierings E, Goulmy E. Spierings E, et al. Among authors: goulmy e. Methods Mol Biol. 2012;882:509-30. doi: 10.1007/978-1-61779-842-9_29. Methods Mol Biol. 2012. PMID: 22665253

4

Hematopoietic system-specific antigens as targets for cellular immunotherapy of hematological malignancies.

Mutis T, Goulmy E. Mutis T, et al. Among authors: goulmy e. Semin Hematol. 2002 Jan;39(1):23-31. doi: 10.1053/shem.2002.29248. Semin Hematol. 2002. PMID: 11799526 Review.

5

Efficient induction of minor histocompatibility antigen HA-1-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA.

Mutis T, Ghoreschi K, Schrama E, Kamp J, Heemskerk M, Falkenburg JH, Wilke M, Goulmy E. Mutis T, et al. Among authors: goulmy e. Biol Blood Marrow Transplant. 2002;8(8):412-9. doi: 10.1053/bbmt.2002.v8.pm12234166. Biol Blood Marrow Transplant. 2002. PMID: 12234166 Free article.

6

Minor histocompatibility antigens--big in tumour therapy.

Spierings E, Wieles B, Goulmy E. Spierings E, et al. Among authors: goulmy e. Trends Immunol. 2004 Feb;25(2):56-60. doi: 10.1016/j.it.2003.12.002. Trends Immunol. 2004. PMID: 15102363 Review.

7

Risk assessment in haematopoietic stem cell transplantation: minor histocompatibility antigens.

Hambach L, Spierings E, Goulmy E. Hambach L, et al. Among authors: goulmy e. Best Pract Res Clin Haematol. 2007 Jun;20(2):171-87. doi: 10.1016/j.beha.2006.09.002. Best Pract Res Clin Haematol. 2007. PMID: 17448955 Review.

8

Molecular typing methods for minor histocompatibility antigens.

Spierings E, Goulmy E. Spierings E, et al. Among authors: goulmy e. Methods Mol Med. 2007;134:81-96. doi: 10.1007/978-1-59745-223-6_7. Methods Mol Med. 2007. PMID: 17666745 Review.

9

Exogenous Addition of Minor H Antigen HA-1+ Dendritic Cells to Skin Tissues Ex Vivo Causes Infiltration and Activation of HA-1-Specific Cytotoxic T Cells.

Kim YH, Vyth-Dreese FA, Schrama E, Pavel S, Bajema I, Goulmy E, Spierings E. Kim YH, et al. Among authors: goulmy e. Biol Blood Marrow Transplant. 2011 Jan;17(1):69-77. doi: 10.1016/j.bbmt.2010.08.006. Epub 2010 Aug 12. Biol Blood Marrow Transplant. 2011. PMID: 20708701 Free article.

10

CD80-Transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens.

Mutis T, Schrama E, Melief CJ, Goulmy E. Mutis T, et al. Among authors: goulmy e. Blood. 1998 Sep 1;92(5):1677-84. Blood. 1998. PMID: 9716596 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters